We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $191B
1-Year Est. Return 45.21%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
+4%
1 Year Est. Return
+45.21%
3 Year Est. Return
+136.44%
5 Year Est. Return
+183.49%
10 Year Est. Return
+678.03%
AUM
$61.8B
AUM Growth
+$7.3B
Cap. Flow
+$3.47B
Cap. Flow %
5.61%
Top 10 Hldgs %
15.31%
Holding
2,670
New
59
Increased
1,417
Reduced
325
Closed
89

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$106M
2
NXPI icon
NXP Semiconductors
NXPI
+$93.6M
3
BABA icon
Alibaba
BABA
+$90M
4
XOM icon
ExxonMobil
XOM
+$83.7M
5
CHTR icon
Charter Communications
CHTR
+$82.8M

Sector Composition

Rank Sector Weight
1 Healthcare 15.13%
2 Technology 14.52%
3 Consumer Staples 10.68%
4 Consumer Discretionary 10.21%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARNA
2201
DELISTED
Arena Pharmaceuticals Inc
ARNA
$660K ﹤0.01%
38,610
SGYP
2202
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$659K ﹤0.01%
173,350
LDR
2203
DELISTED
Landauer Inc
LDR
$659K ﹤0.01%
16,000
SGMO
2204
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$658K ﹤0.01%
113,560
MYE icon
2205
Myers Industries
MYE
$1.23B
$657K ﹤0.01%
45,600
SGRY icon
2206
Surgery Partners
SGRY
$1.99B
$657K ﹤0.01%
+36,700
New +$546K
HZO icon
2207
MarineMax
HZO
$1.15B
$655K ﹤0.01%
38,600
KTWO
2208
DELISTED
K2M Group Holdings, Inc
KTWO
$655K ﹤0.01%
42,200
+3,300
+8% +$46.5K
ARCB icon
2209
ArcBest
ARCB
$3.03B
$653K ﹤0.01%
40,200
IVC
2210
DELISTED
Invacare Corporation
IVC
$650K ﹤0.01%
53,600
ASPS icon
2211
Altisource Portfolio Solutions
ASPS
$65.1M
$646K ﹤0.01%
2,900
-188
-6% -$41.6K
MED icon
2212
Medifast
MED
$132M
$645K ﹤0.01%
19,400
EZPW icon
2213
Ezcorp Inc
EZPW
$1.66B
$642K ﹤0.01%
84,950
+4,100
+5% +$23.1K
FMSA
2214
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
$642K ﹤0.01%
83,300
+12,400
+17% +$61.1K
MOD icon
2215
Modine Manufacturing
MOD
$10.7B
$640K ﹤0.01%
72,700
WCIC
2216
DELISTED
WCI Communities, Inc.
WCIC
$640K ﹤0.01%
37,850
+4,000
+12% +$68.4K
OME
2217
DELISTED
Omega Protein
OME
$638K ﹤0.01%
31,900
-3,400
-10% -$63.5K
POWL icon
2218
Powell Industries
POWL
$7.59B
$637K ﹤0.01%
48,600
CEL
2219
DELISTED
Cellcom Israel, Ltd.
CEL
$637K ﹤0.01%
95,408
+4,310
+5% +$31.9K
OFG icon
2220
OFG Bancorp
OFG
$2.22B
$636K ﹤0.01%
76,600
SHAK icon
2221
Shake Shack
SHAK
$2.88B
$634K ﹤0.01%
17,400
-900
-5% -$32.7K
AAIC
2222
DELISTED
Arlington Asset Investment Corp.
AAIC
$634K ﹤0.01%
48,700
SIOX
2223
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$634K ﹤0.01%
6,175
EVH icon
2224
Evolent Health
EVH
$470M
$632K ﹤0.01%
32,900
+15,600
+90% +$214K
HAYN
2225
DELISTED
Haynes International, Inc.
HAYN
$632K ﹤0.01%
19,700

Similar funds

Swiss National Bank's Q2 2016 Portfolio in Review

As of Q2 2016, Swiss National Bank held 2,670 positions worth $61.8B, up 13% from $54.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Swiss National Bank deployed $3.47B of net new capital in Q2 2016, opening 59 new positions and adding to 1,417 existing holdings. Its largest new stake was Under Armour Class C: 522,612 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Kimberly-Clark, an estimated $19.6M trimmed.

  • Swiss National Bank's largest Q2 2016 buy was Under Armour Class C: 522,612 shares worth $19M.
  • Swiss National Bank added most to Apple in Q2 2016, an estimated $106M increase.
  • Swiss National Bank's biggest Q2 2016 reduction was Kimberly-Clark, cutting an estimated $19.6M.
  • Swiss National Bank fully exited Brookfield in Q2 2016, selling an estimated $162M.
  • Swiss National Bank's ten largest holdings make up 15% of its $61.8B portfolio in Q2 2016.
  • Swiss National Bank opened 59 new positions and closed 89 in Q2 2016.
  • Swiss National Bank's portfolio value rose 13% quarter-over-quarter to $61.8B.

Based on Swiss National Bank's 13F filing for Q2 2016, filed 3 Aug 2016.